Panagora Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Hold |
|
|||||
|
2025
Q1 | $629K | Buy |
|
|||||
|
2024
Q4 | $824K | Sell |
|
|||||
|
2024
Q3 | $951K | Sell |
|
|||||
|
2024
Q2 | $1.05M | Buy |
|
|||||
|
2024
Q1 | $817K | Sell |
|
|||||
|
2023
Q4 | $1.87M | Buy |
|
|||||
|
2023
Q3 | $601K | Hold |
|
|||||
|
2023
Q2 | $655K | Buy |
|
|||||
|
2023
Q1 | $99.4K | Buy |
|
|||||
|
2022
Q4 | $114K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5K | Hold |
|
|||||
|
2020
Q1 | $6K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $151K | Sell |
|
|||||
|
2018
Q2 | $120K | Sell |
|
|||||
|
2018
Q1 | $155K | Hold |
|
|||||
|
2017
Q4 | $137K | Sell |
|
|||||
|
2017
Q3 | $165K | Buy |
|